BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ - Get Free Report) shot up 0.3% during trading on Tuesday . The stock traded as high as $1.84 and last traded at $1.81. 2,210,568 shares changed hands during trading, a decline of 96% from the average session volume of 62,169,492 shares. The stock had previously closed at $1.81.
BioRestorative Therapies Price Performance
The firm has a market cap of $3.08 billion, a P/E ratio of -1.76 and a beta of 102.36. The stock's 50-day simple moving average is $1.74 and its two-hundred day simple moving average is $1.77.
BioRestorative Therapies Company Profile
(
Get Free Report)
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Articles
Before you consider BioRestorative Therapies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioRestorative Therapies wasn't on the list.
While BioRestorative Therapies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
